• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.net
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Tech

VASRO GmbH > Press > Tech
VASRO GmbH

Tracking Biopharma Layoffs and Restructuring in 2025

  • February 5, 2025
  • Pharma & Biotech, Pharma & Biotech, Tech, Tech
Thermo Fisher cuts 300 jobs in viral vector manufacturing amid 2025 biopharma layoffs, driven by economic pressures, R&D shifts, and pipeline failures.
Continue Reading
VASRO GmbH

Meta doubles down on AI innovation after DeepSeek’s groundbreaking model

  • January 31, 2025
  • Tech, Tech
Meta's AI strategy evolves with a $65B investment by 2025, open-source models like Llama, and lessons from DeepSeek's cost-efficient AI breakthroughs.
Continue Reading
VASRO GmbH

AI Trends Shaping IT Market Strategies in 2025

  • January 30, 2025
  • Tech, Tech
How AI is revolutionizing IT market strategies in 2025 with hyper-personalization, edge AI, and automation driving innovation and operational efficiency.
Continue Reading
VASRO GmbH

Exploring the Future of AI Memory Chips in 2025

  • January 24, 2025
  • Tech, Tech
AI memory chips are driving innovation with advancements in HBM technology, energy efficiency, and scalability, shaping AI applications and market growth by 2025.
Continue Reading
VASRO GmbH

Exploring Enterprise Technology Trends for 2024 and Beyond

  • October 16, 2024
  • Tech, Tech
Explore 2024's enterprise tech trends: AI, cloud, cybersecurity, IoT, and data analytics. Stay ahead with strategic tech investments and innovation.
Continue Reading
VASRO GmbH

Introduction to equity valuation and financial analysis

  • September 27, 2024
  • Pharma & Biotech, Tech
Gain insights into stock valuation and financial analysis. Learn about valuation methods, financial reports and the importance of return and risk.
Continue Reading

Posts pagination

Previous 1 2

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY September 7, 2026
Zaptec ASA: Europe’s Largest AC Charging Brand, With the Service Layer Priced at Zero – VASRO Initiates Coverage With BUY August 31, 2026
Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not — First Half 2026 Update August 12, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • Info@vasro.net
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.